Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-28 @ 6:21 PM
Study NCT ID:
NCT01573702
Status:
COMPLETED
Last Update Posted:
2021-01-12
First Post:
2012-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-12-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-15
Completion Date Type:
ACTUAL
First Submit Date:
2012-04-05
First Submit QC Date:
None
Study First Post Date:
2012-04-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-16
Results First Submit QC Date:
None
Results First Post Date:
2021-01-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-17
Last Update Post Date:
2021-01-12
Last Update Post Date Type:
ACTUAL